Projected Age-Based Prevalence and Management Cost of Chronic Hepatitis C-Induced Advanced Liver Disease in the United States

被引：0
|
作者：
Deniz, Baris [1 ]
Velez, Fulton [1 ]
Pyenson, Bruce [2 ]
Iwasaki, Kosuke [2 ]
机构：
[1] Vertex Pharmaceut Inc, Cambridge, MA USA
[2] Milliman Inc, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷
关键词：
D O I：
10.14309/00000434-201010001-01100
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1100
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [21] Population-based differences in Schistosoma mansoni- and hepatitis C-induced disease
    Blanton, RE
    Salam, EA
    Kariuki, HC
    Magak, P
    Silva, LK
    Muchiri, EM
    Thiongo, F
    Abdel-Meghid, IE
    Butterworth, AE
    Reis, MG
    Ouma, JH
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (11): : 1644 - 1649
  • [22] The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
    Jim Young
    Nina Weis
    Harald Hofer
    William Irving
    Ola Weiland
    Emiliano Giostra
    Juan Manuel Pascasio
    Lluis Castells
    Martin Prieto
    Roelien Postema
    Cinira Lefevre
    David Evans
    Heiner C. Bucher
    Jose Luis Calleja
    BMC Infectious Diseases, 17
  • [23] The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
    Young, Jim
    Weis, Nina
    Hofer, Harald
    Irving, William
    Weiland, Ola
    Giostra, Emiliano
    Manuel Pascasio, Juan
    Castells, Lluis
    Prieto, Martin
    Postema, Roelien
    Lefevre, Cinira
    Evans, David
    Bucher, Heiner C.
    Luis Calleja, Jose
    BMC INFECTIOUS DISEASES, 2017, 17
  • [24] High prevalence of occult hepatitis B in patients with advanced liver disease and patients with hepatitis C
    Raouf, AA
    El Saeed, H
    Ghnaiem, N
    Bassiouny, A
    El Ghazzawy, H
    Waked, I
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S142 - S142
  • [25] High prevalence of occult hepatitis B in patients with advanced liver disease and patients with hepatitis C
    Raouf, AA
    El Kom, S
    El Saeed, H
    El Kom, S
    Ghnaiem, N
    El Kom, S
    Bassiouny, A
    El Ghazzawy, H
    El Kom, S
    Waked, I
    HEPATOLOGY, 2005, 42 (04) : 722A - 722A
  • [26] High prevalence of occult hepatitis B in patients with advanced liver disease and patients with hepatitis C
    Abbas, Raouf Ahmed
    Hala, El Saeed
    Ghnaiem, Naglaa
    Bassuny, Ashraf
    El-Ezzawy, Hosam
    Waked, Imam
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A117 - A117
  • [27] Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States
    Gish, Robert G.
    Cohen, Chari A.
    Block, Joan M.
    Brosgart, Carol L.
    Block, Timothy M.
    Clary, Ryan
    Le, Loc T.
    Ninburg, Michael H.
    Sandt, Lorren
    Kowdley, Kris V.
    HEPATOLOGY, 2015, 62 (05) : 1339 - 1341
  • [28] The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
    Armstrong, GL
    Alter, MJ
    McQuillan, GM
    Margolis, HS
    HEPATOLOGY, 2000, 31 (03) : 777 - 782
  • [29] The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States
    Arguedas, MR
    Heudebert, GR
    Fallon, MB
    Stinnett, AA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (03): : 721 - 728
  • [30] PREVALENCE OF COMPENSATED ADVANCED CHRONIC LIVER DISEASE (CACLD) IN THE UNITED STATES: INSIGHTS FROM NHANES 2017-2020
    Goyal, Ritik Mahaveer
    Doshi, Apoorva
    Maheshwari, Supriya
    Qureshi, Imran
    Gupta, Udita
    Kim, David
    Gaglio, Paul
    HEPATOLOGY, 2024, 80
12345